Article
Digital light delivery system allows adjustment of lens, eliminates need for explantation
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
ForSight Robotics completes $125M Series B funding to address global surgeon shortage
(EyePod) From idea to impact: Navigating ophthalmic innovation
Mount Sinai’s NYEE unveils Center for Refractive Solutions
Formosa Pharmaceuticals grants Harrow commercial rights in US to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia